Participate in a Migraine Research Study
If you or someone you love suffers from migraines, perhaps you should consider participating in a clinical research study. Perhaps the best reason to participate in a clinical trial is so that you can take an active role in your health care, by educating yourself regarding your condition. You will obtain access to top quality medical care from our Board Certified physicians at a medical research healthcare facility specializing in migraines.
Health insurance is not necessary to participate. Patients who qualify for our clinical trials will receive all study related care and treatment at no cost. In some cases you may be compensated for your time and travel. You may even gain access to research treatments before they are widely available.
Interested in learning about our migraine research studies going on at Premiere Research Institute? Contact us by calling (561) 296-3850 or fill out the form below.
The ultimate goal of migraine research is the relief of all migraine episodes. Today it is possible for this to be accomplished in a small percentage of people and ultimately we hope to vastly improve the percentage over the next several years.
Today we do have new treatments primarily because we have a greater understanding of how a migraine is caused. Some of our latest research focuses on controlling the neuropeptide called calcitonin gene related peptide [CGRP]. If we can block this neurotransmitter from working we can significantly influence the potential for a migraine to develop. Today we are studying compounds that can block CGRP at the molecular level.
Articles about Migraines
To read one of our most recent articles about Migraines just click the title of the article.
Migraine and tension headaches are often painful, but there are notable differences between them that many people are unaware of. It is important to know what these differences are, as they can be pivotal in deciding to seek out a proper diagnosis and treatment. While...read more
A new small molecule calcitonin gene-related peptide (CGRP) drug in phase 3 clinical trials has shown promising relief of migraine symptoms when administered as an acute single-dose treatment. The migraine drug, Rimegepant, relieved pain and other bothersome migraine...read more
A large global survey of migraine patients which included over 11,000 respondents from 31 countries found that many migraine sufferers commonly deal with functional impairments at work due to their symptoms. Respondents of the survey had at least four migraine days...read more
Adults with migraine now have an additional preventative treatment option available to them, thanks to a new and unique migraine medication that has been approved by the Food and Drug Administration (FDA). Aimovig (erenumab-aooe) is a novel, first of its kind...read more
Today, there are a variety of different migraine prevention options which can help ease the lifestyle burdens that migraine sufferers often live with. There are several goals to migraine prevention, such as a lessening of functional impairments and disability,...read more
Migraine is a neurological disease that affects approximately one billion people worldwide. In fact, according to the Migraine Research Foundation, it is the third most prevalent disease in the world. To give you an idea of how common and impactful migraine is in the...read more
A migraine during the workday can make things more difficult to deal with. According to the Migraine Research Foundation, over 90 percent of those with migraine are either not able to work or function normally when one occurs (O’Donnell, 2018). However, there are...read more
While migraines themselves are often painful and disruptive to a person’s life, many who suffer from migraines also suffer from the stigmatization of the disease, which can lead to a discrediting of the illness, discrimination, family issues, and more. The...read more
Physical Activity for Mitigating Pediatric Post-Concussive Symptoms A study published in the Journal of the American Medical Association (JAMA) found that children and adolescents who continued their physical activities within one week of an acute concussion had a...read more
According to a study from the University of Eastern Finland, there may be a higher risk of chronic headache from low vitamin D levels. The Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD), published in the journal Scientific Reports, examined whether an...read more